Acquisitions
ClearTrial
On March 29, 2012, Oracle announced that it has agreed to acquire ClearTrial, a leading provider of cloud-based Clinical Trial Operations and analytics products that make the planning, sourcing, and tracking of clinical projects and financial performance faster and more accurate. The transaction has closed.
The combination of Oracle and ClearTrial is expected to deliver the most comprehensive closed-loop clinical trial management offering from planning to payment. ClearTrial's activity-based costing solutions use embedded intelligence based on deep industry expertise to help life sciences companies manage the rising costs and increasing complexities of bringing new therapies to market. Together, Oracle expects to enable companies to significantly improve their ability to manage clinical trials across geographies, outsourcers, therapeutic areas, and trial phases resulting in a better return on their R&D capital investments.
ClearTrial customers and partners: Please use your existing contacts for support, professional services, and sales.
|
Oracle is currently reviewing the existing ClearTrial product roadmap and will be providing guidance to customers in accordance with Oracle's standard product communication policies. Any resulting features and timing of release of such features as determined by Oracle's review of ClearTrial's product roadmap are at the sole discretion of Oracle. All product roadmap information, whether communicated by ClearTrial or by Oracle, does not represent a commitment to deliver any material, code, or functionality, and should not be relied upon in making purchasing decisions. It is intended for information purposes only, and may not be incorporated into any contract. Cautionary Statement Regarding Forward-Looking Statements |